Search results
Raw milk health risks significantly outweigh any potential benefits − food scientists and...
The Conversation via Yahoo News· 2 days agoIt was written by: Juan Silva, Mississippi State University; Joel Komakech, Mississippi State...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 21 hours agoProgression-free survival is how long patients live before their cancer worsens. The company added...
AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThis recent blow comes after Truqap received approval from the US Food and Drug Administration (FDA)...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 4 days agoRegeneron said that the therapy is under review by the US Food and Drug Administration with a target...
Erasca kicks off Phase III trial for naporafenib combo therapy in melanoma
Clinical Trials Arena via Yahoo Finance· 3 days agoThe company has initiated a Phase III trial investigating the...naporafenib and Mikinist. The...
Johnson & Johnson seeks FDA nod for new cancer treatment By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) for a subcutaneous formulation of amivantamab, aimed at...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 3 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 4 days agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
Will price cuts at Target, Walmart actually attract value-focused consumers?
Food Navigator USA· 1 day agoLast month, several large retailers slashed their prices on everyday items to attract consumers back...
New EHA data reveal how badly Gilead's $4.9B bet on CD47 imploded
FierceBiotech· 7 days agoMagrolimab showed worse performances compared with placebo across multiple efficacy and safety...